| Financial Year |
March 31 2023 |
| Monetary Funds |
193,941,067.70 |
| Held-for-trading Financial Assets |
150,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
400,726,654.14 |
| Advances to Suppliers |
184,490,646.57 |
| Other Receivables |
82,600,573.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,407,105.91 |
| Total Current Assets |
1,052,166,047.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,709,662.33 |
| Investment Properties |
372,820,932.00 |
| Fixed Assetes |
7,668,092.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
232,602,528.42 |
| R&D expenses |
217,523,606.30 |
| Goodwill |
1,877,547,582.00 |
| Long-Term Deferred and Prepaid Expenses |
8,018,909.54 |
| Deferred Income Tax Assets |
155,255,491.25 |
| Other Non-Current Assets |
460,972,062.12 |
| Sub-Total of Non-Current Assets |
3,879,498,031.92 |
| Total Assets |
4,931,664,079.70 |
| Short-Term Loans |
140,666,565.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
112,917,347.16 |
| Accounts Received In Advance |
504,769.09 |
| Employee Compensation Payable |
9,740,788.27 |
| Taxes Payable |
1,948,726.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,845,628.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,245,968.70 |
| Other Current Liabilities |
2,704,091.12 |
| Sub-Total of Current Liabilities |
409,115,229.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
54,913,312.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
61,082,339.80 |
| Total Liabilities |
470,197,569.44 |
| Paid-In Capital(Or Share Stock) |
956,665,066.00 |
| Capital Surplus |
2,817,125,772.33 |
| Surplus Reserve |
162,446,585.14 |
| LESS:Treasury Stock |
50,096,846.08 |
| Undistributed Profits |
441,215,866.99 |
| Minority Stockholder's Interest |
134,273,772.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,327,192,737.90 |
| Owner's Equity（Stockholder's Equity） |
4,461,466,510.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,931,664,079.70 |
